Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

S1 Guideline: Therapy of generalized pustular psoriasis.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Same author

Cefazolin as an alternative in patients with a history of penicillin or β-lactam antibiotic allergy: A case overview.

Allergologie select·2026

Same author

Transient p53/p21 activation selectively protects healthy human hair follicles and their stem cells from chemotherapy.

The Journal of clinical investigation·2026

Same author

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Cancers·2026

Same author

Extraction of keratin particles as intact protein sequences from chicken feathers and their characterization.

Biomaterials and biosystems·2026

Same author

Indirect Comparison of Cal/BDP PAD-Cream vs Cal/BDP Foam in Patients with Plaque Psoriasis Meeting the Rule of Tens.

Dermatology and therapy·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Dermal targeting using colloidal carrier systems with linoleic acid.

Alexandra S B Goebel¹, Ulrich Knie, Christoph Abels

¹Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V

|February 23, 2010

Summary

This summary is machine-generated.

A novel microemulsion effectively delivers linoleic acid for skin barrier repair. This colloidal carrier system significantly enhances linoleic acid penetration into skin layers compared to traditional creams, aiding barrier regeneration.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Related Experiment Videos

Last Updated: Jun 16, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Area of Science:

Dermatology and Pharmaceutical Sciences
Colloid and Surface Chemistry

Background:

Local treatment is crucial for chronic skin diseases like xerosis.
Linoleic acid is vital for maintaining skin barrier integrity.
Effective delivery systems are needed to enhance linoleic acid's therapeutic potential.

Purpose of the Study:

To develop and characterize a microemulsion for enhanced dermal delivery of linoleic acid.
To compare the efficacy of the microemulsion with a standard cream for linoleic acid delivery.
To evaluate the potential of the microemulsion for skin barrier regeneration and anti-inflammatory effects.

Main Methods:

Development and physiochemical characterization of a linoleic acid-loaded microemulsion.
In vitro penetration studies comparing the microemulsion with a cream.
Quantification of linoleic acid in different skin layers post-application.
Statistical analysis of penetration data.

Main Results:

The microemulsion demonstrated superior delivery of linoleic acid compared to a cream.
Significantly higher concentrations of linoleic acid were found in all skin layers with the microemulsion.
Up to 23% of the applied dose reached the skin via the microemulsion, versus 8% with the cream.
Linoleic acid accumulation in the epidermis increased with incubation time when using the microemulsion.

Conclusions:

The developed microemulsion is an innovative and effective vehicle for enhanced dermal delivery of linoleic acid.
This system significantly improves linoleic acid penetration, supporting skin barrier regeneration.
The microemulsion holds promise for treating skin conditions requiring barrier repair and potentially offers anti-inflammatory benefits.